| Date Filed | Type | Description |
| 06/16/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 2,000 shares
@ $24.15, valued at
$48.3k
|
|
| 05/19/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 5,947 shares
@ $22.5, valued at
$133.8k
Exercised 5,947 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 17,131 options to buy
@ $21.75, valued at
$372.6k
Granted 10,384 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 350 shares
@ $18.78, valued at
$6.6k
Exercised 840 restricted stock units
@ $0 |
|
| 04/11/2022 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Sold 1,025 shares
@ $27.05, valued at
$27.7k
Exercised 2,977 restricted stock units
@ $0 |
|
| 04/07/2022 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 13,793 options to buy
@ $25.75, valued at
$355.2k
Granted 8,039 restricted stock units
@ $0 |
|
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 15,860 restricted stock units
@ $0 |
|
| 02/25/2021 |
4
| Kihara James (Principal Accounting Officer) has filed a Form 4 on ACADIA PHARMACEUTICALS INC|
Txns:
| Granted 6,187 options to buy
@ $49.74, valued at
$307.7k
Granted 3,360 restricted stock units
@ $0 |
|
| 08/07/2020 |
3/A
| Kihara James (Principal Accounting Officer) has filed a Form 3/A on ACADIA PHARMACEUTICALS INC |
| 07/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |